|
Volumn 22, Issue 19, 2014, Pages 5290-5297
|
Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors
|
Author keywords
Antiviral activity; Drug design; HIV; Molecular modeling; NNRTIs; Pyrimidine; SAR; SCR
|
Indexed keywords
1 N (2 BROMO 4 SULFONAMIDEPHENYL) 4 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO]BENZOATE;
2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO] N (2 NITROPHENYL)ACETAMIDE;
3 CHLORO 4 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO]BENZOIC ACID;
3 CHLORO N HYDROXY 4 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO]BENZAMIDE;
3 CHLORO N METHOXY 4 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO]BENZAMIDE;
4 [4 [[5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]METHYL] 1H 1,2,3 TRIAZOL 1 YL]BENZOIC ACID;
4 [[1 (2 BROMOBENZYL) 1H 1,2,3 TRIAZOL 4 YL]METHYLTHIO] 5 (NAPHTHALEN 1 YL)PYRIMIDINE;
4 [[1 (4 METHOXYBENZYL) 1H 1,2,3 TRIAZOL 4 YL]METHYLTHIO] 5 (NAPHTHALEN 1 YL)PYRIMIDINE;
6 CHLORO 5 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO]PICOLINIC ACID;
ACETANILIDE DERIVATIVE;
ARYLAZINYLTHIOACETANILIDE DERIVATIVE;
DELAVIRDINE;
EFAVIRENZ;
ETHYL 2 [3 CHLORO 4 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO]BENZAMIDO]ACETATE;
ETHYL 2 [3 CHLORO 4 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO]BENZAMIDO]PROPANOATE;
ETHYL 3 BROMO 4 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO]BENZOATE;
ETHYL 3 CHLORO 4 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO]BENZOATE;
METHYL 3 BROMO 4 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO]BENZOATE;
METHYL 3 CHLORO 4 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO]BENZOATE;
METHYL 4 [2 [5 (NAPHTHALEN 1 YL)PYRIMIDIN 4 YLTHIO]ACETAMIDO] 3 NITROBENZOATE;
NEVIRAPINE;
NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;
PYRIMIDINYLTHIOACETANILIDE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
PYRIMIDINE DERIVATIVE;
ANTIVIRAL ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG DESIGN;
DRUG STRUCTURE;
DRUG SYNTHESIS;
EC50;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MOLECULAR MODEL;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
VIRUS INHIBITION;
CHEMICAL STRUCTURE;
CHEMISTRY;
DOSE RESPONSE;
DRUG EFFECTS;
GROWTH, DEVELOPMENT AND AGING;
MICROBIAL SENSITIVITY TEST;
SYNTHESIS;
VIRUS REPLICATION;
ACETANILIDES;
ANTI-HIV AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DESIGN;
HIV-1;
MICROBIAL SENSITIVITY TESTS;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
PYRIMIDINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
VIRUS REPLICATION;
|
EID: 84907543301
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2014.08.001 Document Type: Article |
Times cited : (13)
|
References (30)
|